Dave Inc./DE (DAVEW) stock
DAVEWNasdaqFinance ServicesFiscal year ends December 31Also trades as DAVE
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 9/304% above fair value
$0.60−0.29 (-32.58%)
Close on Oct 30, 2026Market cap $4.04BP/E 20.5Yield –
Dave EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Dave's EPS for the twelve months ending Jun 30, 2026 was $15.42, up 307.9% year over year. For fiscal 2025 it was $13.53, up 222.9% from the year before. The highest annual figure on record is $13.53 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.53 | +222.9% |
| FY2024 | Dec 31, 2024 | $4.19 | – |
| FY2023 | Dec 31, 2023 | -$4.07 | – |
| FY2022 | Dec 31, 2022 | -$11.12 | – |
| FY2021 | Dec 31, 2021 | -$4.69 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0.49 | -21.0% |
| Q1 FY2026 | Mar 31, 2026 | $4.02 | +104.1% |
| Q4 FY2025 | Dec 31, 2025 | $4.57 | +294.0% |
| Q3 FY2025 | Sep 30, 2025 | $6.34 | +21033.3% |
| Q2 FY2025 | Jun 30, 2025 | $0.62 | +31.9% |
| Q1 FY2025 | Mar 31, 2025 | $1.97 | -24.2% |
| Q4 FY2024 | Dec 31, 2024 | $1.16 | +11500.0% |
| Q3 FY2024 | Sep 30, 2024 | $0.03 | – |
| Q2 FY2024 | Jun 30, 2024 | $0.47 | – |
| Q1 FY2024 | Mar 31, 2024 | $2.60 | – |
| Q4 FY2023 | Dec 31, 2023 | $0.01 | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.01 | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.90 | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.19 | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.83 | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.06 | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.34 | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.91 | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.92 | – |
| Q2 FY2021 | Jun 30, 2021 | -$0.32 | – |
| Q1 FY2021 | Mar 31, 2021 | $0.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics